DOI: 10.25881/BPNMSC.2019.98.52.003

Authors

Vorobeva Yu.S., Shugushev Z.Kh., Faibushevich A.G., Maximkin D.A.

Peoples Friendship University of Russia (RUDN University), Moscow

Abstract

The article presents the long-term results of of bioabsorbable vascular scaffolds («Absorb BVS») implantation compared to everolimus-eluting coronary stents at 12, 24 and 36 months after percutaneous coronary intervention in patients with ischemic heart disease, including concomitant type 2 diabetes. The real scaffolds absorbing are shown, as well as the comparable efficacy of bioabsorbable scaffolds with everolimus-eluting stents according to the frequency of adverse cardiovascular events.

Keywords: bioabsorbable scaffolds, ischemic heart disease, diabetes mellitus.

References

1. Abizaid, A., Costa, J.Jr.,Bartorelli, A.L., Whitbourn, R., van Geuns, R.J., Chevalier, B., Patel, T., Seth, A., Stuteville, M., Dorange, C., Cheong, W.F., Sudhir, K., Serruys, P.W. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled // EuroIntervention. – 2014. – 10(12). – P. 1396–1401.

2. Abizaid A, Ribamar Costa J Jr, Bartorelli AL, Whitbourn R, van Geuns RJ, Chevalier B, Patel T, Seth A, Stuteville M, Dorange C, Cheong WF, Sudhir K, Serruys PW; ABSORB EXTEND investigators. The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled. EuroIntervention. 2015;10(12):1396–1401. doi: 10.4244/EIJV10I12A243.

3. Bourantas CV, Papafaklis MI, Garcia-Garcia HM, Farooq V, Diletti R, Muramatsu T, Zhang Y, Kalatzis FG, Naka KK, Fotiadis DI, Onuma Y, Michalis LK, Serruys PW. Short and long-term implications of a bioresorbable vascular scaffold implantation on the local endothelial shear stress patterns. JACC Cardiovasc Interv. 2014;7(1):100–101. doi: 10.1016/j.jcin.2013.01.139.

4. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissman N, Waksman R; PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet. 2007;369(9576):1869–1875. doi: 10.1016/S0140-6736(07)60853-8.

5. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, Dangas G, Mehran R, Lansky AJ, Kreps EM, Collins M, Stone GW, Moses JW, Leon MB. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Amer Coll Cardiol. 2005;45(7):995–998. doi: 10.1016/j.jacc.2004.12.066.

6. Gogas BD, King SB 3rd, Samady H. Bioresorbable polymeric scaffolds for coronary revascularization: lessons learnt from ABSORB III, ABSORB China and ABSORB Japan. Glob Cardiol Sci Pract. 2015;2015(5):62. doi: 10.5339/gcsp.2015.62.

7. Kimura T, Kozuma K, Tanabe K, Nakamura S, Yamane M, Muramatsu T, Saito S, Yajima J, Hagiwara N, Mitsudo K, Popma JJ, Serruys PW, Onuma Y, Ying S, Cao S, Staehr P, Cheong WF, Kusano H, Stone GW; ABSORB Japan Investigators. A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan. Eur Heart J. 2015;36(47):3332–3342. doi: 10.1093/eurheartj/ehv435.

8. Ormiston JA, De Vroey F, Serruys PW, Webster MW. Bioresorbable polymeric vascular scaffolds: a cautionary tale. Circ Cardiovasc Interv. 2011;4(5):535–538. doi: 10.1161/CIRCINTERVENTIONS.111.963710.

9. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade. Eur Heart J. 2012;33(1):16–25b. doi: 10.1093/eurheartj/ehr384.

10. Serruys PW, Onuma Y, Dudek D, Smits PC, Koolen J, Chevalier B, de Bruyne B, Thuesen L, McClean D, van Geuns RJ, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Hebert KM, Sudhir K, Garcia-Garcia HM, Ormiston JA. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. J Am Coll Cardiol. 2011;58(15):1578–1588. doi: 10.1016/j.jacc.2011.05.050.

11. Testa L, Biondi Zoccai G, Tomai F, Ribichini F, Indolfi C, Tamburino C, Bartorelli A, Petronio AS, Bedogni F, De Carlo M. Italian Diffuse/Multivessel Disease ABSORB Prospective Registry (IT-DISAPPEARS). Study design and rationale. J Cardiovasc Med (Hagerstown). 2015;16(3):253–258. doi: 10.2459/JCM.0000000000000219.

For citation

Vorobeva Yu.S., Shugushev Z.Kh., Faibushevich A.G., Maximkin D.A. Long-term results of bioabsorbable vascular scaffolds implantation on patients with coronary artery disease. Bulletin of Pirogov National Medical & Surgical Center. 2019;14(2):14-19. (In Russ.) https://doi.org/10.25881/BPNMSC.2019.98.52.003